6B1Z
Crystal Structure of Glutamate-tRNA Synthetase from Elizabethkingia anophelis
Summary for 6B1Z
Entry DOI | 10.2210/pdb6b1z/pdb |
Descriptor | Glutamate--tRNA ligase, FORMIC ACID, 1,2-ETHANEDIOL, ... (5 entities in total) |
Functional Keywords | ssgcid, elizabethkingia anophelis, glutamate--trna ligase, ligase, structural genomics, seattle structural genomics center for infectious disease |
Biological source | Elizabethkingia anophelis |
Cellular location | Cytoplasm : A0A1T3FQP0 |
Total number of polymer chains | 1 |
Total formula weight | 59832.06 |
Authors | Seattle Structural Genomics Center for Infectious Disease (SSGCID) (deposition date: 2017-09-19, release date: 2017-10-04, Last modification date: 2024-07-03) |
Primary citation | Brooks, L.,Subramanian, S.,Dranow, D.M.,Mayclin, S.J.,Myler, P.J.,Asojo, O.A. Crystal structures of glutamyl-tRNA synthetase from Elizabethkingia anopheles and E. meningosepticum. Acta Crystallogr.,Sect.F, 78:306-312, 2022 Cited by PubMed Abstract: Elizabethkingia bacteria are globally emerging pathogens that cause opportunistic and nosocomial infections, with up to 40% mortality among the immunocompromised. Elizabethkingia species are in the pipeline of organisms for high-throughput structural analysis at the Seattle Structural Genomics Center for Infectious Disease (SSGCID). These efforts include the structure-function analysis of potential therapeutic targets. Glutamyl-tRNA synthetase (GluRS) is essential for tRNA aminoacylation and is under investigation as a bacterial drug target. The SSGCID produced, crystallized and determined high-resolution structures of GluRS from E. meningosepticum (EmGluRS) and E. anopheles (EaGluRS). EmGluRS was co-crystallized with glutamate, while EaGluRS is an apo structure. EmGluRS shares ∼97% sequence identity with EaGluRS but less than 39% sequence identity with any other structure in the Protein Data Bank. EmGluRS and EaGluRS have the prototypical bacterial GluRS topology. EmGluRS and EaGluRS have similar binding sites and tertiary structures to other bacterial GluRSs that are promising drug targets. These structural similarities can be exploited for drug discovery. PubMed: 35924598DOI: 10.1107/S2053230X22007555 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.6 Å) |
Structure validation
Download full validation report